Author:
Murakami Yoshiaki,Uemura Kenichiro,Sudo Takeshi,Hashimoto Yasushi,Kondo Naru,Nakagawa Naoya,Takahashi Shinya,Sueda Taijiro
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference24 articles.
1. National Comprehensive Cancer Network (2016) NCCN clinical practice guidelines in oncology. Pancreatic adenocarcinoma, version 2, 2016 edn. http://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf . Accessed 2 Oct 2016
2. Kato H, Usui M, Isaji S, Nagakawa T, Wada K, Unno M, Nakao A, Miyakawa S, Ohta T (2013) Clinical features and treatment outcome of borderline resectable pancreatic head/body cancer: a multi-institutional survey by the Japanese Society of Pancreatic Surgery. J Hepatobiliary Pancreat Sci 20:601–610. doi: 10.1007/s00534-013-0595-1
3. Murakami Y, Satoi S, Sho M, Motoi F, Matsumoto I, Kawai M, Honda G, Uemura K, Yanagimoto H, Shinzeki M, Kurata M, Kinoshita S, Yamaue H, Unno M (2015) National comprehensive cancer network resectability status for pancreatic carcinoma predicts overall survival. World J Surg 39:2306–2314. doi: 10.1007/s00268-015-3096-3
4. Nakachi K, Furuse J, Kinoshita T, Kawashima M, Ishii H, Ikeda M, Mitsunaga S, Shimizu S (2010) A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancer. Cancer Chemother Pharmacol 66:527–534. doi: 10.1007/s00280-009-1193-4
5. Shinchi H, Maemura K, Mataki Y, Kurahara H, Sakoda M, Ueno S, Hiraki Y, Nakajo M, Natsugoe S, Takao S (2012) A phase II study of oral S-1 with concurrent radiotherapy followed by chemotherapy with S-1 alone for locally advanced pancreatic cancer. J Hepatobiliary Pancreat Sci 19:152–158. doi: 10.1007/s00534-011-0400-y
Cited by
52 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献